Istituto Oncologico Candiolo

Fingerprint The fingerprint is based on mining the text of the scientific documents related to the associated persons. Based on that an index of weighted terms is created, which defines the key subjects of research unit

Neoplasms Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Colorectal Neoplasms Medicine & Life Sciences
Hepatocyte Growth Factor Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Proto-Oncogene Proteins c-met Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2018 2018

Research Output 1966 2018

5 Citations
exemestane
letrozole
Tamoxifen
Aromatase Inhibitors
Breast Neoplasms
exemestane
letrozole
Tamoxifen
Aromatase Inhibitors
Breast Neoplasms

Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial

Maugeri Centre for Telehealth and Telecare (MCTT), 2018, In : The Lancet Oncology. 19, 4, p. 474-485 12 p.

Research output: Contribution to journalArticle